ALPS Advisors’s Tectonic Therapeutic TECX Stock Holding History

ALPS Advisors’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$472K	Sell	15,286 -83	-0.5%	-$2.04K	﹤0.01%	907
2025 Q4	$321K	Buy	+15,369	New	+$286K	﹤0.01%	933
2021 Q2	–	Sell	-6,250	Closed	-$952K	–	922
2021 Q1	$952K	Buy	6,250 +761	+14%	+$124K	0.01%	401
2020 Q4	$918K	Buy	5,489 +1,617	+42%	+$287K	0.01%	396
2020 Q3	$605K	Sell	3,872 -224	-5%	-$45.1K	0.01%	403
2020 Q2	$858K	Buy	+4,096	New	+$844K	0.01%	355

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

ALPS Advisors's TECX Position: Q1 2026 in Review

ALPS Advisors reduced its Tectonic Therapeutic (TECX) stake by 0.54% in Q1 2026, selling an estimated $2.04K and leaving 15,286 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #907.

ALPS Advisors first reported a position in TECX in Q2 2020 and has held it in 6 quarters since. The position peaked at $952K in Q1 2021. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

ALPS Advisors held 15,286 shares of Tectonic Therapeutic worth $472K as of Q1 2026.
ALPS Advisors sold 83 Tectonic Therapeutic shares in Q1 2026, an estimated $2.04K.
Tectonic Therapeutic made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #907 holding.
ALPS Advisors first reported a position in Tectonic Therapeutic in Q2 2020 and has held it in 6 quarters since.
ALPS Advisors's Tectonic Therapeutic position peaked at $952K in Q1 2021.
111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.